| Dr Rajendra Potluri, MD | |
|
801 Broadway N, Fargo, ND 58102-3641 | |
| (701) 234-2731 | |
| (701) 234-2158 |
| Full Name | Dr Rajendra Potluri |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 30 Years |
| Location | 801 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679562953 | NPI | - | NPPES |
| 22610 | Other | ND | BLUE SHIELD |
| 12271 | Medicaid | ND | |
| 28580 | Other | ND | BLUE SHIELD |
| CF8850 | Other | ND | RAILROAD MEDICARE |
| 28582 | Other | ND | BLUE SHIELD |
| 28579 | Other | ND | BLUE SHIELD |
| 28581 | Other | ND | BLUE SHIELD |
| 25978 | Other | ND | BLUE SHIELD |
| 28583 | Other | ND | BLUE SHIELD |
| P00003010 | Other | ND | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 9227 (North Dakota) | Primary |
| 207R00000X | Internal Medicine | 9227 (North Dakota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | Hospital |
| Sanford Hillsboro | Hillsboro, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sanford Medical Center Fargo | 8426967803 | 1094 |
News Archive
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an "AIDS-free generation" is attainable, "[b]ut not if treatment continues to take precedence over prevention."
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.
› Verified 5 days ago
| Entity Name | Sanford Clinic North |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942241351 PECOS PAC ID: 4284546151 Enrollment ID: O20031112000221 |
News Archive
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an "AIDS-free generation" is attainable, "[b]ut not if treatment continues to take precedence over prevention."
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.
› Verified 5 days ago
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an "AIDS-free generation" is attainable, "[b]ut not if treatment continues to take precedence over prevention."
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rajendra Potluri, MD Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Dr Rajendra Potluri, MD 801 Broadway N, Fargo, ND 58102-3641 Ph: (701) 234-2731 |
News Archive
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.
In this Foreign Affairs opinion piece, Mead Over, a senior fellow at the Center for Global Development, says the goal of an "AIDS-free generation" is attainable, "[b]ut not if treatment continues to take precedence over prevention."
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse. Colorectal cancer is the third leading cause of cancer-related death in the Western world.
GenVec, Inc. today announced its financial results for the second quarter ended June 30, 2010.
› Verified 5 days ago
Malik Muhammad Anwar Ul Haq, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 | |
Christina Harmon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 | |
Riley Clark, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2000 | |
Irina Hillman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 Fax: 701-417-2535 | |
Hannah Margaret Schradick, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-234-5933 | |
James D Fowler, PA Hospitalist Medicare: Medicare Enrolled Practice Location: 5225 23rd Ave S, Fargo, ND 58104 Phone: 701-417-2575 | |
Weimin Hao, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 737 Broadway, Fargo, ND 58122 Phone: 701-234-2731 Fax: 701-234-2158 |